These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 28168366)

  • 1. Evolution of patency rates of self-expandable bare metal stents for endovascular treatment of femoro-popliteal arterial occlusive disease: Does stent design matter?
    Treitl KM; Woerner B; Schinner R; Czihal M; Notohamiprodjo S; Hoffmann U; Treitl M
    Eur Radiol; 2017 Sep; 27(9):3947-3955. PubMed ID: 28168366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial.
    Rastan A; Krankenberg H; Baumgartner I; Blessing E; Müller-Hülsbeck S; Pilger E; Scheinert D; Lammer J; Gißler M; Noory E; Neumann FJ; Zeller T
    Circulation; 2013 Jun; 127(25):2535-41. PubMed ID: 23694965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Hohman S; Pearl G; Theune B
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-dilatation of an interwoven nitinol stent using a paclitaxel-coated balloon for revascularization of complex femoro-popliteal lesions.
    Stahlberg E; Allmendinger AC; Anton S; Planert M; Jacob F; Barkhausen J; Goltz JP
    Cardiovasc Interv Ther; 2021 Jul; 36(3):338-346. PubMed ID: 32803671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bypass Versus Interwoven Nitinol Stents for Long Femoro-Popliteal Occlusions: A Propensity Matched Analysis.
    Gostev AA; Osipova OS; Saaya SB; Bugurov SV; Cheban AV; Rabtsun AA; Ignatenko PV; Karpenko AA
    Cardiovasc Intervent Radiol; 2022 Jul; 45(7):929-938. PubMed ID: 35581472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Self-Expanding Interwoven Nitinol Stent for Treating Femoropopliteal Artery Disease: 12-Month Results of Single-Center First-in-Man Study.
    Yang S; Ni Q; Wang W; Chen J; Guo X; Ye M; Zhang L; Xue G
    J Endovasc Ther; 2024 Oct; 31(5):955-963. PubMed ID: 36927094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Jaff MR;
    Circ Cardiovasc Interv; 2010 Jun; 3(3):267-76. PubMed ID: 20484101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interwoven Nitinol Stents versus Drug Eluting Stents in the Femoro-Popliteal Segment: A Propensity Matched Analysis.
    Saratzis A; Rudarakanchana N; Patel S; Diamantopoulos A; Lea T; Corbo B; Gradinariu G; Katsanos K; Zayed H;
    Eur J Vasc Endovasc Surg; 2019 Nov; 58(5):719-727. PubMed ID: 31500990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for long-segment femoro-popliteal obstructions: initial experience with a 4-F compatible self-expanding nitinol stent and review of the literature.
    Baumann F; Do DD; Willenberg T; Baumgartner I; Diehm N
    J Cardiovasc Surg (Torino); 2012 Aug; 53(4):475-80. PubMed ID: 22854527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three year results of endovascular therapy with a new generation nitinol stent for femoro-popliteal artery lesions - a single-center outcome analysis of a subcohort of MISAGO 2 study.
    Kralj I; Boos I; Müller-Bühl U
    Vasa; 2013 Sep; 42(5):340-9. PubMed ID: 23989069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial.
    Rastan A; Krankenberg H; Baumgartner I; Blessing E; Müller-Hülsbeck S; Pilger E; Scheinert D; Lammer J; Beschorner U; Noory E; Neumann FJ; Zeller T
    J Endovasc Ther; 2015 Feb; 22(1):22-7. PubMed ID: 25775675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined intraoperative iliac artery stents and femoro-popliteal bypass for multilevel atherosclerotic occlusive disease.
    Liu C; Guan H; Li Y; Zheng Y; Liu W
    Chin Med Sci J; 2001 Sep; 16(3):165-8. PubMed ID: 12899330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stent-assisted recanalization of femoropopliteal arterial occlusive disease. Influence of stent design on patency rates].
    Treitl M; Reiser MF; Treitl KM
    Radiologe; 2016 Mar; 56(3):233-9. PubMed ID: 26842999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Rocha-Singh KJ; Beckman JA; Ansel G; Lyden SP; Schneider P; Mehta M; Dake M; Mullin CM; Jaff MR;
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1250-1256. PubMed ID: 28303688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year results of primary stenting for TASC II D lesions of the superficial femoral and popliteal arteries.
    Astarcıoglu MA; Kılıt C; Sen T; Durmus HI; Kalcık M; Gursoy MO; Yesın M; Asarcıklı LD; Gozubuyuk G; Amasyalı B
    Acta Cardiol; 2017 Feb; 72(1):36-40. PubMed ID: 28597743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of endovascular therapy with nitinol stent implantation for TASC II A/B femoro-popliteal artery lesions: 4 years' experience.
    Iida O; Nanto S; Uematsu M; Ikeoka K; Okamoto S; Dohi T; Fujita M; Nagata S
    Circ J; 2009 Nov; 73(11):2143-7. PubMed ID: 19724155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.